التهاب الجلد التأتبي المتوسط إلى الشديد المقاوم لعلاج الحمامات المخففة بالمبيض

References

DOI: 10.1016/j.anai.2023.11.009

Recommendation 11: In patients with moderate-severe atopic dermatitis, the JTF panel suggests, in addition to topical therapy, dilute bleach baths over usual (no dilute bleach-based) baths (conditional recommendation, low-certainty evidence).

In patients with moderate-severe atopic dermatitis refractory, intolerant, or unable to use mid-potency topical treatment, the JTF panel suggests adding allergen immunotherapy to standard topical treatment over not adding (conditional recommendation, moderate-certainty evidence).

Based on a combination of clinician-reported AD severity (eg, SCORAD), AIT likely improved AD severity by 50% or more from baseline compared with no AIT (40% vs 26%), with similar estimates of effect for SCIT and SLIT.

Crude estimates of median time to effect were 5 (range 1-12) months.